Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Share-based Compensation: 2019-2024

Historic Share-based Compensation for P3 Health Partners (PIII) over the last 6 years, with FY2024 value amounting to $5.8 million.

  • P3 Health Partners' Share-based Compensation fell 3815.12% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.3 million, marking a year-over-year decrease of 293.21%. This contributed to the annual value of $5.8 million for FY2024, which is 379.66% down from last year.
  • P3 Health Partners' Share-based Compensation amounted to $5.8 million in FY2024, which was down 379.66% from $6.0 million recorded in FY2023.
  • P3 Health Partners' 5-year Share-based Compensation high stood at $19.4 million for FY2022, and its period low was $447475.0 during FY2020.
  • In the last 5 years, P3 Health Partners' Share-based Compensation had a median value of $5.8 million in 2024 and averaged $7.1 million.
  • Its Share-based Compensation has fluctuated over the past 5 years, first tumbled by 6918.68% in 2023, then crashed by 379.66% in 2024.
  • Annual analysis of 5 years shows P3 Health Partners' Share-based Compensation stood at $447475.0 in 2020, then soared by 727.09% to $3.7 million in 2021, then surged by 424.29% to $19.4 million in 2022, then crashed by 69.19% to $6.0 million in 2023, then fell by 3.8% to $5.8 million in 2024.
  • Its last three reported values are $5.8 million in FY2024, $6.0 million for FY2023, and $19.4 million during FY2022.